CJC-1295 + IPAMORELIN 10mg
Description
Overview
A research-grade peptide combination of CJC-1295 + IPAMORELIN 10 mg formulated for in vitro investigation of growth-hormone-axis signaling and receptor pharmacology. Supplied as a lyophilized blend for stability and analytical precision; QC-verified for identity and batch purity.
Research context
Intended for non-clinical in vitro studies, this blend is designed to model combined GHRH- and GHSR-axis activation, prolonged and acute GH-axis signaling interactions, and downstream metabolic or secretory responses in controlled laboratory assays.
Product Information
- Product nameCJC-1295 (no DAC) + Ipamorelin Blend
- ContentsCJC-1295 (no DAC) and Ipamorelin — ratio and unit size as labeled
- AppearanceWhite to off-white lyophilized powder
- FormLyophilized solid blend
- Purity>99% per component (HPLC verified)
Storage & Handling
- Store at −20 °C; protect from moisture and light.
- Lyophilized for stability; avoid repeated freeze–thaw cycles after reconstitution.
- Follow institutional protocols for reconstitution and aseptic handling.
Research Applications
- In vitro GHRH receptor and GHSR (ghrelin receptor) binding and signaling assays
- cAMP/PKA pathway and somatotroph activation studies
- Cellular secretion and endocrine axis modeling
- Mechanistic combination and dose-response interaction studies
Legal & Safety
For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use. No therapeutic, diagnostic, or dosing claims are made. This product has not been evaluated by the U.S. Food and Drug Administration (FDA) and is not intended to diagnose, treat, cure, or prevent any disease.
